Safety and efficacy of droxidopa (Norther™) for the treatment of symptomatic neurogenic orthostatic by (NOH) in patients with Parkinson's disease (PD)

被引：0

|

作者：

Mathias, C. J.

Kaufmann, H.

机构：

来源：

MOVEMENT DISORDERS | 2010年 / 25卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S405 / S406

页数：2

相关论文

共 50 条

[21] Responder Analyses of Droxidopa in Patients with Symptomatic Neurogenic Orthostatic Hypotension
Rowse, Gerald
Hewitt, Lawrence
Shields, Alan
Freeman, Roy
Kaufmann, Horacio
NEUROLOGY, 2016, 86
[22] Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension
Hauser, Robert A.
Heritier, Stephane
Rowse, Gerald J.
Hewitt, L. Arthur
Isaacson, Stuart H.
CLINICAL NEUROPHARMACOLOGY, 2016, 39 (05) : 220 - 226
[23] Responder analyses of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Rowse, G. J.
Hewitt, L. A.
Shields, A.
Freeman, R.
Kaufmann, H.
MOVEMENT DISORDERS, 2015, 30 : S116 - S117
[24] Durability of effect with long-term, open-label droxidopa treatment in patients with symptomatic neurogenic orthostatic hypotension (NOH 303)
Isaacson, S.
Shill, H.
Vernino, S.
Cioffi, C.
Hutchman, R.
MOVEMENT DISORDERS, 2012, 27 : S424 - S425
[25] Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Brent P. Goodman
Daniel Claassen
Ali Mehdirad
Clinical Autonomic Research, 2017, 27 : 17 - 19
[26] Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Goodman, Brent P.
Claassen, Daniel
Mehdirad, Ali
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S17 - S19
[27] A multicenter, open-label study to assess the long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension (NOH 304)
Shill, H.
Vernino, S.
Hutchman, R.
Adkins, L.
Isaacson, S.
MOVEMENT DISORDERS, 2012, 27 : S428 - S428
[28] Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Daniel Claassen
Mark Lew
Clinical Autonomic Research, 2017, 27 : 13 - 14
[29] Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Claassen, Daniel
Lew, Mark
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S13 - S14
[30] Efficacy and Safety of Droxidopa for the Treatment of Patients with Symptomatic Neurogenic Orthostatic Hypotension during 12 Weeks of Open-Label Treatment in a Phase 4 Study
Gorny, Stephen
Hewitt, L. Arthur
Lindsten, Annika
Kymes, Steven
Favit, Antonella
ANNALS OF NEUROLOGY, 2019, 86 : S183 - S183

← 1 2 3 4 5 →